ClinVar Miner

Submissions for variant NM_153676.4(USH1C):c.379G>A (p.Gly127Arg)

gnomAD frequency: 0.00002  dbSNP: rs768207716
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000223498 SCV000272877 uncertain significance not specified 2016-03-29 criteria provided, single submitter clinical testing The p.Gly127Arg variant in USH1C has not been previously reported in individuals with hearing loss. This variant has been identified in 1/65418 European chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs768207716). Computational prediction tools and conservation analyses sug gest that the p.Gly127Arg variant may impact the protein, though this informatio n is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Gly127Arg variant is uncertain.
Counsyl RCV000672839 SCV000797985 uncertain significance Usher syndrome type 1C; Autosomal recessive nonsyndromic hearing loss 18A 2018-02-20 criteria provided, single submitter clinical testing
Invitae RCV001241209 SCV001414213 uncertain significance not provided 2022-10-04 criteria provided, single submitter clinical testing This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 127 of the USH1C protein (p.Gly127Arg). This variant is present in population databases (rs768207716, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with USH1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 229607). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Natera, Inc. RCV001828088 SCV002080213 uncertain significance Usher syndrome type 1C 2021-05-19 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.